Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 28, 2011; 17(16): 2143-2149
Published online Apr 28, 2011. doi: 10.3748/wjg.v17.i16.2143
Published online Apr 28, 2011. doi: 10.3748/wjg.v17.i16.2143
Table 1 Characteristics of enrolled patients with hepatocellular carcinoma
| Characteristics | Gene group(n = 68) | Control group(n = 82) | Statistic analysis |
| Age | 43.5 (20 - 72) | 45.7 (18 - 75) | NS |
| Sex (M/F) | 43/25 | 40/42 | NS |
| Child class A | 41 | 43 | NS |
| Child class B | 27 | 39 | NS |
| UICC TNM classification | |||
| Stage I and II | 0 | 0 | NS |
| Stage III | 31 (46.5%) | 60 (73.2%) | NS |
| Stage IV | 37 (54.4%) | 22 (26.8%) | NS |
| Size of main tumors | |||
| ≥ 5 cm | 53 (77.9%) | 61 (74.3%) | NS |
| < 5 cm | 15 (22.1%) | 21 (25.7%) | NS |
-
Citation: Guan YS, Liu Y, He Q, Li X, Yang L, Hu Y, La Z.
p53 gene therapy in combination with transcatheter arterial chemoembolization for HCC: One-year follow-up. World J Gastroenterol 2011; 17(16): 2143-2149 - URL: https://www.wjgnet.com/1007-9327/full/v17/i16/2143.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i16.2143